Cocaine is often “cut” with various additives to increase the profitability of the drug. One of the most common additives on today’s market is levamisole, an anthelmintic medication used to destroy and expel parasitic worms in animals. The use of levamisole-contaminated cocaine can result in agranulocytosis and vasculitis (inflammation and constriction of small blood vessels). The resulting clotting and decrease in peripheral blood flow lead to cutaneous lesions, particularly on the ears, face, hands, and feet, and in severe cases can cause generalized tissue necrosis throughout the entire body. Treatment is generally supportive, and symptoms typically abate with complete cessation of cocaine use. However, symptoms may recur with subsequent cocaine use and, as this case illustrates, severe neutropenia and extensive vasculitis may lead to overwhelming sepsis and death.
Skip Nav Destination
Article navigation
1 August 2017
Toxicology|
August 01 2017
Levamisole-Adulterated Cocaine Leading to Fatal Vasculitis: A Case Report
Belinda B. Hammond, RN, MSN, CCRN;
Belinda B. Hammond is the critical care clinical nurse educator and coordinator of the new graduate Academy for Critical Care Nursing at Cone Health, Greensboro, North Carolina.
Corresponding author: Belinda B. Hammond, rn, msn, ccrn, Cone Health, 1200 N. Elm Street, Greensboro, NC 27401 (email: [email protected]).
Search for other works by this author on:
Jordan Craven, RN, BSN
Jordan Craven, RN, BSN
Jordan Craven is a registered nurse in the cardiac ICU, Novant Health Forsyth Medical Center, Winston Salem, North Carolina.
Search for other works by this author on:
Crit Care Nurse (2017) 37 (4): 49–57.
Citation
Belinda B. Hammond, Jordan Craven; Levamisole-Adulterated Cocaine Leading to Fatal Vasculitis: A Case Report. Crit Care Nurse 1 August 2017; 37 (4): 49–57. doi: https://doi.org/10.4037/ccn2017977
Download citation file:
Sign in
Don't already have an account? Register
Short-term Access
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access